ArticlesDrug Discovery and DevelopmentGeneral Interest

Globally Aware Genomes — an Informatics Challenge

The Human Genome Project was completed nearly two decades ago, in 2003. The primary vision of this project was to produce a human reference genome, a representative example of the set of genes in one idealized individual human. However, the currently available reference genomes do not represent the genetic diversity found across different human populations. As such, any downstream products (drugs therapies, personalized medicine, etc.) derived from the human genome will not accurately represent the vast majority of the human population.
READ MORE →
BioRad.io podcast banner
ArticlesPodcasts

BioRad.io Podcast Series

The BioRad.io podcast series is focused on R&D informatics, introducing you to people responsible for implementing systems and technologies to a diverse set of use-cases. Join us every month to see what you can learn.
READ MORE →
Lab of the Future banner image
ArticlesDrug Discovery and DevelopmentGeneral Interest

Lab of the Future

In an effort to increase the return on investment of research and development, pharmaceutical companies are constantly looking for ways to reduce costs. One way to do this is to incorporate technology and minimize human interaction. As a result, scientists will have more time to focus on the design and analysis of experiments. How will the Lab of the Future reflect these changes?
READ MORE →
ArticlesFeatured StoriesGeneral Interest

Active Machine Learning in Drug Discovery

Drug discovery and development are both time and resource intensive since a lot of different compounds need to be screened across a lot of different targets. See how machine learning models can be used to predict screening results and how active learning algorithms can be used to efficiently select which experiments to perform in order to build those models.
READ MORE →
ArticlesGeneral Interest

Data Integration and Visualization Approaches

Over the past several decades, research informatics (RIS) environments within BioPharma organizations have evolved dramatically, increasing the demand for simple and easy data integration and visualization. Learn about the tools available to address this need and what the future could hold.
READ MORE →
ArticlesFeatured StoriesGeneral Interest

Cloud Migration Strategies for BioPharma

Many BioPharma organizations are moving to the cloud in order to improve the performance and speed, cost, physical and personnel resources, security, back up, and sharing/collaboration associated with large, complex datasets. Learn about the different strategies used in migrating to the cloud.
READ MORE →
The Potential for CRISPR Gene Editing in HIV
ArticlesDrug Discovery and DevelopmentFeatured Stories

The Potential for CRISPR Gene Editing in HIV

The advent of CRISPR as a gene editing tool appears to have revolutionized drug discovery and development in a very short time. CRISPR-Cas9 technology is also being utilized to target HIV, to mutate or cut out the provirus. Read about what’s new in potential treatments for HIV and the challenges facing the industry.
READ MORE →